Log In
BCIQ
Print this Print this
 

N-acetylglucosaminidase alpha (NAGLU)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting N-acetylglucosaminidase alpha (NAGLU)

BCIQ
Print ChartPrint this
Phase of DevelopmentPhase I/II
Endocrine / Metabolic

4




 Products Targeting N-acetylglucosaminidase alpha (NAGLU)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$8,829.3M

$4,473.5M

$9.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/23/2015

$8,788.4M

$4,473.5M

0

05/18/2015

$40.9M

0

$9.0M

Get a free BioCentury Trial today